Dr Janet Woodcock was Director of the Center for Drug Evaluation and Research at the FDA and then the Deputy Commissioner between 1999 and 2006.
Dr Steven Galson replaced her as Director of the Center for Drug Evaluation and Research at the FDA.
Federal regulations demand that a public calendar be maintained detailing all significant meetings between the upper echelon of the FDA and any representatives of Big Pharma.
Congressional investigators responding to mounting public concerns about corruption at the FDA have found the diary to be largely blank.
The FDA could not explain the ‘oversight’. Neither Woodcock or Galson were available for comment.